Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity.
Kumagai
K
K
Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.
Takeda
K
K
Hashimoto
W
W
Seki
S
S
Ogasawara
K
K
Anzai
R
R
Takahashi
M
M
Sato
M
M
Rikiishi
H
H
D000818:Animals; D006801:Humans; D018664:Interleukin-12 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D018123:Receptors, Interleukin / Q000502:physiology; D053707:Receptors, Interleukin-12; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology
D018123:Receptors, Interleukin; D053707:Receptors, Interleukin-12; D018664:Interleukin-12